News Powered By AI
News Powered By AI
NHS England has discontinued the Medical Training Initiative, a program that provided 400-500 overseas doctors annual placements in UK hospitals since 2011, drawing criticism from medical colleges.
The NHS must prepare for annual summer heat crises with the same intensity as winter pressures, health secretary Yvette Cooper warns, as heatwaves become routine across the UK.
England’s obesity rate among adults aged 16 and over has doubled from 15% in 1993 to 30% in 2024, affecting 14 million adults despite 14 separate government obesity strategies over three decades.
Eli Lilly’s Foundayo, a daily weight-loss pill and GLP-1 medication, has received UK approval, becoming the first such treatment authorized in Europe. It treats obesity and type 2 diabetes but requires separate NHS approval for weight-loss coverage.
The NHS is rolling out a new treatment called teplizumab that can delay type 1 diabetes onset for years, marking a potential shift from century-old insulin-based approaches.
The CMS finalized a rule barring federal Medicaid and CHIP funds for pediatric gender-affirming medications and surgery, set to take effect October 13. Legal experts anticipate challenges but note the rule’s procedural approach may make it more defensible than previous administration actions.
